COMMUNIQUÉS West-GlobeNewswire

-
AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
31/05/2024 -
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
31/05/2024 -
JDRF Walk to Cure Diabetes
31/05/2024 -
Marche pour la guérison du diabète FRDJ
31/05/2024 -
DBV Technologies Announces Plan to Implement ADS Ratio Change
31/05/2024 -
DBV Technologies annonce son intention de modifier le ratio d'ADS
31/05/2024 -
Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum
31/05/2024 -
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
31/05/2024 -
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
31/05/2024 -
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
31/05/2024 -
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
31/05/2024 -
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the Human Healthspan
31/05/2024 -
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
31/05/2024 -
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
31/05/2024 -
Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
31/05/2024 -
SS Innovations Engages BDO as its new Auditor
31/05/2024 -
Morphic to Participate in Jefferies Global Healthcare Conference
31/05/2024 -
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
31/05/2024 -
Bionomics Limited Announces Private Placement of up to $70.0 Million
31/05/2024
Pages